Managing malignant pleural effusion

被引：9

作者：

Wahla, Ali Saeed ^{[1
]}

Uzbeck, Mateen ^{[1
]}

Abu El Sameed, Yaser ^{[1
]}

Zoumot, Zaid ^{[1
]}

机构：

[1] Cleveland Clin Abu Dhabi, Resp & Crit Care Inst, Abu Dhabi, U Arab Emirates

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2019年 / 86卷 / 02期

关键词：

PLEURODESIS; MANAGEMENT; CATHETER; PALLIATION; EFFICACY; TALC; TUBE;

D O I：

10.3949/ccjm.86a.17095

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Malignant pleural effusion can be managed in different ways, including clinical observation, thoracentesis, placement of an indwelling pleural catheter, and chemical pleurodesis. The optimal strategy depends on a variety of clinical factors. This article uses cases to illustrate the rationale for determining the best approach in different situations.

引用

页码：95 / 99

页数：5

共 50 条

[31] Postoperative outcome after palliative treatment of malignant pleural effusion
Markowiak, Till
Ried, Michael
Grosser, Christian
Hofmann, Hans-Stefan
Hillejan, Ludger
Hecker, Erich
Semik, Michael
Lesser, Thomas
Kugler, Christian
Seifert, Sven
Scheubel, Robert
THORACIC CANCER, 2022, 13 (15) : 2158 - 2163
[32] Implantation of permanent pleural catheter for palliation of malignant pleural effusion
Meier, Michelle
Mortensen, Marie Riis
Larsen, Lene Unmack
CANCER MANAGEMENT AND RESEARCH, 2016, 8 : 129 - 133
[33] Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis
Puri, Varun
Pyrdeck, Tanya L.
Crabtree, Traves D.
Kreisel, Daniel
Krupnick, Alexander S.
Colditz, Graham A.
Patterson, G. Alexander
Meyers, Bryan F.
ANNALS OF THORACIC SURGERY, 2012, 94 (02) : 374 - 380
[34] Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion
Bhatnagar, R.
Keenan, E. K.
Keenan, E. K.
Morley, A. J.
Kahan, B. C.
Stanton, A. E.
Haris, M.
Harrison, R. N.
Mustafa, R. A.
Bishop, L. J.
Ahmed, L.
West, A.
Holme, J.
Evison, M.
Munavvar, M.
Sivasothy, P.
Herre, J.
Cooper, D.
Roberts, M.
Guhan, A.
Hooper, C.
Walters, J.
Saba, T. S.
Chakrabarti, B.
Gunatilake, S.
Psallidas, I.
Walker, S. P.
Bibby, A. C.
Smith, S.
Stadon, L. J.
Zahan-Evans, N. J.
Lee, Y. C. G.
Harvey, J. E.
Rahman, N. M.
Miller, R. F.
Maskell, N. A.
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (14) : 1313 - 1322
[35] Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion
Keeratichananont, Warangkana
Limthon, Theeranan
Keeratichananont, Suriya
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (02) : 42 - 48
[36] Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion
Shi, Xin-Yu
Yi, Feng-Shuang
Wang, Zheng
Qiao, Xin
Zhai, Kan
THORACIC CANCER, 2020, 11 (02) : 320 - 328
[37] Management of Malignant Pleural Effusion
Jack A. Kastelik
Lung, 2013, 191 : 165 - 175
[38] Management of malignant pleural effusion
Tattersall, M
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (03): : 394 - 396
[39] Predictors of lung entrapment in malignant pleural effusion
Trovisco, R.
Freitas, C.
Serino, M.
Ferreira, P.
Martins, B.
Coelho, D.
Melo, N.
Fernandes, G.
Magalhaes, A.
Bastos, H. N.
PULMONOLOGY, 2024, 30 (06): : 555 - 562
[40] Malignant Pleural Effusion: Presentation, Diagnosis, and Management
Gayen, Shameek
AMERICAN JOURNAL OF MEDICINE, 2022, 135 (10) : 1188 - 1192

← 1 2 3 4 5 →